Quick view Royalty Rates in Pharmaceutical and Biotechnology Deals 2010 to 2024 £3,225.16 - £8,068.96 Choose Options
Quick view Precision Oncology: Collaboration and Licensing Deals 2016-2024 £3,225.16 - £8,068.96 Choose Options
Quick view Global Proteomics Partnering Terms and Agreements 2016-2023 £3,225.16 - £8,068.96 Choose Options
Quick view COMPUTED TOMOGRAPHY (CT) MARKETS BY APPLICATION, TECHNOLOGY, PLACE AND PRODUCT WITH EXECUTIVE AND CONSULTANT GUIDES 2023 - 2027 £5,647.06 - £11,298.16 Choose Options
Quick view Cancer Immunotherapy Markets - The Race for the Cures: Forecasts for Immuno-Oncology Therapeutics by Cancer, Therapy and Customer with Executive and Consultant Guides 2023 to 2027 £5,647.06 - £11,298.16 Choose Options
Quick view Antibiotic Resistance Markets (Therapeutics): Market Insights and Forecasts by Pathogen and Therapy with Situation Analysis, Executive and Investment Guides 2023 to 2027 £5,647.06 - £11,298.16 Choose Options
Quick view Current Agreements: Life Science Deal Tracker Database (12 month access) £4,839.76 - £20,178.46 Choose Options
Quick view Companion Diagnostics (CDx) Collaboration and Licensing Deals 2010 to 2024 £3,225.16 - £8,068.96 Choose Options
Quick view Diagnostics: Collaboration and Licensing Deals 2019-2024 £3,225.16 - £8,068.96 Choose Options
Quick view Global Infectious Disease Vaccine Partnering Terms and Agreements 2016-2024 £3,225.16 - £8,068.96 Choose Options
Quick view Precision Medicine Collaboration and Licensing Deals 2018-2024 £3,225.16 - £8,068.96 Choose Options
Quick view Metagenomics Markets: Global Market Analysis with Forecasts by Applications, Technologies, Product and User with Executive and Consultant Guides 2023 to 2027 £5,647.06 - £11,298.16 Choose Options